Inositol Anxiety Randomized Trial: What the Evidence Says

Quick Answer

Inositol Anxiety Randomized Trial has 3 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review, 1 research article.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Research has found that prolonged exposure to blue light affects athletes' sleep quality, athletic performance, and cognitive function. [Huang Da (2025); evidence level 1]
• Among esports players, nutritional supplements, sleep regulation, and physical exercise have been identified as factors associated with cognitive function and psychological mood. [Huang Da (2025); evidence level 1]
• The global prevalence of PCOS increased from 36.7 to 69.5 million between 1990 and 2021. [Subakathulla Sumayyah (2026); evidence level 3]
• Emerging evidence underscores that OS is not a mere byproduct of metabolic imbalance but a central driver that disrupts insulin signaling, amplifies androgen biosynthesis, and impairs folliculogenesis. [Subakathulla Sumayyah (2026); evidence level 3]
• Overactive bladder (OAB) is a prevalent and distressing condition in paediatric populations, characterized by urinary urgency, often accompanied by increased daytime frequency and non-monosymptomatic nocturnal enuresis. [Colletti Alessandro (2026); evidence level 4]
• OAB is associated with significant quality-of-life impairments, including low self-esteem, behavioural disturbances, and social withdrawal. [Colletti Alessandro (2026); evidence level 4]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For inositol anxiety randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Huang Da (2025). Nutritional supplements to improve esports player performance: a systematic review of randomized controlled trials. DOI: 10.1080/15502783.2025.2603303. PMCID: PMC12724221. PMID: 41424341. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12724221/
• Subakathulla Sumayyah (2026). Redox-endocrine triad in PCOS: can vitamin D, myo-inositol, and melatonin synergize as bioactive cocktails?. DOI: 10.3389/fendo.2026.1825853. PMCID: PMC13160802. PMID: 42130739. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13160802/
• Colletti Alessandro (2026). Impact of Adjunctive Myo-Inositol and Magnesium Therapy on Paediatric Overactive Bladder: A Retrospective Analysis. DOI: 10.3390/children13050604. PMCID: PMC13204239. PMID: 42194129. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13204239/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.